ASCO Direct Highlights 2022: lung cancer highlights

Share :
Published: 9 Jul 2022
Views: 157
Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA

Dr Tom Stinchcombe gives his thoughts on the latest developments in other therapies treatments in lung cancer from ASCO Direct Highlights 2022, which target the following mutations: MET exon 14, c-MET, BRAF, KRAS, RET, NTRK and NRG1.

Dr Stinchcombe concludes by highlighting the need for broad-based testing to detect these mutations in lung cancer patients.